ENTITY
Frontage Holdings

Frontage Holdings (1521 HK)

59
Analysis
Health CareChina
Frontage Holdings Corporation operates as a biotechnology company. The Company offers clinical trials, bioequivalence studies, medical writing, and agrochemical services. Frontage Holdings serves customers in Hong Kong.
more
Refresh
04 Jul 2019 08:15

Last Week in GER Research: Budweiser, CIMC, Jinxin Fertility, 360 Finance, Zhongliang, and AMTD

Below is a recap of the key IPO and placement research produced by the Global Equity Research team. This week we update on the IPO valuation for...

Logo
463 Views
Share
02 Jul 2019 09:29

Shanghai/​Shenzhen Connect Ideas: Healthcare Inflows Offset by Financials (2019-06-28)

In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...

Logo
470 Views
Share
30 May 2019 12:12

Frontage Holdings (方达控股) Post-IPO Trading Update: Strong Demand and Volume but Fairly Valued

Frontage Holdings IPO attracted strong demand and was priced at the high end of the IPO pricing. In our previous insight, we have discussed that...

Logo
610 Views
Share
30 May 2019 01:07

Frontage Holdings IPO: Bull/​​Bear Case DCF Scenarios

Frontage Holdings (1521 HK) is a global contract research organisation (CRO) which is backed by Hangzhou Tigermed Consulting (300347 CH)....

Logo
632 Views
Share
25 May 2019 01:51

ECM Weekly (25 May 2019) - ESR Cayman, Hansoh Pharma, Tai Hing, China East Edu, Haitong UniTrust

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
x